These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18785287)

  • 1. Anti-HBc screening in Indian blood donors: still an unresolved issue.
    Dhawan HK; Marwaha N; Sharma RR; Chawla Y; Thakral B; Saluja K; Sharma SK; Thakur MK; Jain A
    World J Gastroenterol; 2008 Sep; 14(34):5327-30. PubMed ID: 18785287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
    Karimi G; Zadsar M; Vafaei N; Sharifi Z; FalahTafti M
    Virol J; 2016 Mar; 13():36. PubMed ID: 26944046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.
    Hennig H; Puchta I; Luhm J; Schlenke P; Goerg S; Kirchner H
    Blood; 2002 Oct; 100(7):2637-41. PubMed ID: 12239179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C; Offergeld R
    Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.
    Hedayati-Moghaddam MR; Tehranian F; Mosavat A; Miri R; Ahmadi Ghezeldasht S
    Arch Iran Med; 2024 Jun; 27(6):305-312. PubMed ID: 38855800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.
    Moresco MN; Virgolino Hde A; de Morais MP; da Motta-Passos I; Gomes-Gouvêa MS; de Assis LM; Aguiar KR; Lombardi SC; Malheiro A; Cavalheiro Nde P; Levi JE; Torres KL
    Vox Sang; 2014 Jul; 107(1):19-25. PubMed ID: 24697276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?
    Hourfar MK; Walch LA; Geusendam G; Dengler T; Janetzko K; Gubbe K; Frank K; Karl A; Löhr M; Sireis W; Seifried E; Schmidt M
    Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing.
    Miletić M; Bingulac-Popović J; Stojić Vidović M; Hećimović A; Berendika M; Babić I; Đogić V; Samardžija M; Barišić K; Jukić I; Mihaljević I
    Transfus Clin Biol; 2019 Nov; 26(4):257-262. PubMed ID: 31153786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.